Hospital returns under drug diversion act
Executive Summary
FDA is expected to issue a guidance letter by the end of the month. FDA will reportedly further liberalize an exemption for returns from the Prescription Drug Marketing Act's hospital resale ban. In a Nov. 3, 1988 guidance, the agency said hospital returns constitute banned resales unless the reason for returns are misshipment or misorder and they occur within 10 days of delivery.